'Lean' MASLD May Sound Better, but Study Suggests Otherwise
(MedPage Today) -- While patients with lean metabolic dysfunction-associated steatotic liver disease (MASLD) have less severe histologic disease, they still had a similar risk of adverse clinical outcomes as those with overweight/obese MASLD, according...
Read more »